The leader in know how and know why in oncology
We leverage provider and payer relationships, oncology experience and proprietary analytics to deliver actionable insights that drive successful market access.
Featured Insights
Article
Beyond AMCs: CAR Ts and Bispecifics in Community Oncology
CAR T-cell and BsAb therapies are powerful but largely confined to AMCs, limiting patient access. Our latest report explores how expanding to community oncology could improve access, addressing key clinical, logistical, and financial challenges.
Read More
Article
Meet Emma: Research Leader and Master Baker
Not only does Emma have over a decade of experience supporting academic health systems and integrated delivery networks (IDNs), but she’s also the go-to for a delicious apple pie.
Emma Bijesse
Podcast
2024 Rewind: Most Memorable Quotes & Insights
Our team looked back on some of the most thought-provoking insights from conversations with key decision-makers in oncology. In this podcast episode, we explore the challenges and opportunities faced by oncologists, payers, and pathway developers.
Ashutosh Sheth
Article
Easier Pathway Access, Greater Pathway Usage
Easier access to oncology pathway recommendations encourages oncologists’ usage and considerations of these recommendations. Our new 2024-2025 Oncology Clinical Pathways Impact Report reveals the variability in pathway integration and usage.
Cindy Chen
The HMP Market Access Insights team helps us understand the interconnectivity between our major customer segments on really important issues and lead us toward better planning and business decisions.
Our Team
Lee Blansett
Executive Vice President
Cindy Chen
Head of Data Analytics
Chris Van Denburg
Director
